L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.
paper
Cited
Public
Unavailable
- Authors
- Gurvich, Nadia; Perna, Fabiana; Farina, Andrea; Voza, Francesca; Menendez, Silvia; Hurwitz, Jerard; Nimer, Stephen D
- Year
- 2010
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 21149733
- DOI
- 10.1073/pnas.1017092108
- PMCID
- PMC3012470
The l3mbtl1 gene is located on the long arm of chromosome 20 (q12), within a region commonly deleted in several myeloid malignancies. L3MBTL1 is a human homolog of the Drosophila polycomb L(3)MBT tumor suppressor protein and thus a candidate tumor suppressor in del(20q12) myeloid disorders. We used the loss-of-function approach to explore the possible tumor suppressive mechanism of L3MBTL1 and found that depletion of L3MBTL1 from human cells causes replicative stress, DNA breaks, activation of the DNA damage response, and genomic instability. L3MBTL1 interacts with Cdc45, MCM2-7 and PCNA, components of the DNA replication machinery, and is required for normal replication fork progression, suggesting that L3MBTL1 causes DNA damage, at least in part, by perturbing DNA replication. An activated DNA damage response and genomic instability are common features in tumorigenesis and a consequence of overexpression of many oncogenes. We propose that the loss of L3MBTL1 contributes to the development of 20q(-) hematopoietic malignancies by inducing replicative stress, DNA damage, and genomic instability.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Detectable clonal mosaicism and its relationship to aging and cancer. | 2012 | 22561519 |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | 2012 | 22561516 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Chronic Wound Initiation: Single-Cell RNAseq of Cutaneous Wound Tissue and Contributions of Oxidative Stress to Initiation of Chronicity. | Jabbari P et al. | — | 2025 | → |
| Nucleosome context regulates chromatin reader preference. | Marunde MR et al. | — | 2025 | → |
| Nutrigenomic insights and cardiovascular benefits of blackberry (Rubus ulmifolius Schott.) and mugwort (Artemisia campestris L.). | Mehiou A et al. | — | 2025 | → |
| Peripheral blood DNA methylation changes are predictive of incident radiographic osteoarthritis development: Data and biospecimens from the osteoarthritis initiative. | Brawner CM et al. | — | 2025 | → |
| Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion. | Huang X et al. | — | 2025 | → |
| Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement. | Suman M et al. | — | 2024 | → |
| Chemical inhibitors targeting histone methylation readers. | Huang X et al. | — | 2024 | → |
| Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma. | Zhang C et al. | — | 2024 | → |
| L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma. | Zhang Z et al. | — | 2024 | → |
| L3MBTL1, a polycomb protein, promotes Osimertinib Acquired resistance through Epigenetic Regulation of DNA damage response in lung adenocarcinoma | Zhang Z et al. | — | 2023 | — |
| Sticky, Adaptable, and Many-sided: SAM protein versatility in normal and pathological hematopoietic states. | Ray S et al. | — | 2023 | → |
| Influences of fresh and frozen embryo transfer on neonatal birthweight and the expression of imprinted genes PEG10 /L3MBTL1 in placenta. | Yang L et al. | — | 2022 | → |
| An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis. | Roy N et al. | — | 2021 | → |
| Targeting epigenetic protein-protein interactions with small-molecule inhibitors. | Linhares BM et al. | — | 2020 | → |
| MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines. | Aygun N et al. | — | 2019 | → |
| Activity-Induced Regulation of Synaptic Strength through the Chromatin Reader L3mbtl1. | Mao W et al. | — | 2018 | → |
| Aging and the rise of somatic cancer-associated mutations in normal tissues. | Risques RA et al. | — | 2018 | → |
| Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer. | Samir N et al. | — | 2018 | → |
| L3MBTL2 orchestrates ubiquitin signalling by dictating the sequential recruitment of RNF8 and RNF168 after DNA damage. | Nowsheen S et al. | — | 2018 | → |
| Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors. | Martin-Trujillo A et al. | — | 2017 | → |
| Melatonin and Hippo Pathway: Is There Existing Cross-Talk? | Lo Sardo F et al. | — | 2017 | → |
| Parental origin of the deletion del(20q) in Shwachman-Diamond patients and loss of the paternally derived allele of the imprinted L3MBTL1 gene. | Nacci L et al. | — | 2017 | → |
| Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics. | Kokate P et al. | — | 2017 | → |
| SETD6 dominant negative mutation in familial colorectal cancer type X. | Martín-Morales L et al. | — | 2017 | → |
| Spatially restricted loading of BRD2 at DNA double-strand breaks protects H4 acetylation domains and promotes DNA repair. | Gursoy-Yuzugullu O et al. | — | 2017 | → |
| The tale of a tail: histone H4 acetylation and the repair of DNA breaks. | Dhar S et al. | — | 2017 | → |
| BRPF3-HBO1 regulates replication origin activation and histone H3K14 acetylation. | Feng Y et al. | — | 2016 | → |
| Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report. | Hatem J et al. | — | 2016 | → |
| Structural aspects of small-molecule inhibition of methyllysine reader proteins. | Milosevich N et al. | — | 2016 | → |
| Targeting epigenetic regulations in cancer. | Ning B et al. | — | 2016 | → |
| A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome. | Arancio W et al. | — | 2015 | → |
| Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. | Yin CC et al. | — | 2015 | → |
| Cognition and mood-related behaviors in L3mbtl1 null mutant mice. | Shen EY et al. | — | 2015 | → |
| Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells. | Yin CC et al. | — | 2015 | → |
| Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis. | Benetatos L et al. | — | 2015 | → |
| Microarray CGH analysis of hematological patients with del(20q). | Wu C et al. | — | 2015 | → |
| Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. | Laurie CC et al. | — | 2014 | → |
| Chromatin reader L(3)mbt requires the Myb-MuvB/DREAM transcriptional regulatory complex for chromosomal recruitment. | Blanchard DP et al. | — | 2014 | → |
| Epigenetic targets and drug discovery: part 1: histone methylation. | Liu Y et al. | — | 2014 | → |
| Myelodysplastic syndromes. | Adès L et al. | — | 2014 | → |
| Recurrent translocation (10;17)(p15;q21) in acute poorly differentiated myeloid leukemia likely results in ZMYND11-MBTD1 fusion. | De Braekeleer E et al. | — | 2014 | → |
| A general molecular affinity strategy for global detection and proteomic analysis of lysine methylation. | Moore KE et al. | — | 2013 | → |
| A role for the malignant brain tumour (MBT) domain protein LIN-61 in DNA double-strand break repair by homologous recombination. | Johnson NM et al. | — | 2013 | → |
| Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions. | Aziz A et al. | — | 2013 | → |
| Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. | James LI et al. | — | 2013 | → |
| Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity. | Jørgensen S et al. | — | 2013 | → |
| Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancer. | Yokota S et al. | — | 2013 | → |
| Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. | Maupetit-Méhouas S et al. | — | 2013 | → |
| The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface. | Camerino MA et al. | — | 2013 | → |
| Detectable clonal mosaicism and its relationship to aging and cancer. | Jacobs KB et al. | — | 2012 | → |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | Laurie CC et al. | — | 2012 | → |
| Flipping the switch from g1 to s phase with e3 ubiquitin ligases. | Rizzardi LF et al. | — | 2012 | → |
| Histone recognition by human malignant brain tumor domains. | Nady N et al. | — | 2012 | → |
| JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg? | Scott LM et al. | — | 2012 | → |
| Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies. | Okada M et al. | — | 2012 | → |
| PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. | Beck DB et al. | — | 2012 | → |
| Transformation of primary myelofibrosis with 20q- in Philadelphia-positive acute lymphoblastic leukemia: case report and review of literature. | Jurisic V et al. | — | 2012 | → |
| Constitutional and acquired autosomal aneuploidy. | Jackson-Cook C | — | 2011 | → |
| Coupling mitosis to DNA replication: the emerging role of the histone H4-lysine 20 methyltransferase PR-Set7. | Brustel J et al. | — | 2011 | → |
| Deletion of chromosome 20q: friend or foe? | Hasserjian RP et al. | — | 2011 | → |
| Drug discovery toward antagonists of methyl-lysine binding proteins. | Herold JM et al. | — | 2011 | → |
| Genetic and epigenetic complexity in myeloproliferative neoplasms. | Cross NC | — | 2011 | → |
| L3MBTL1 deficiency directs the differentiation of human embryonic stem cells toward trophectoderm. | Hoya-Arias R et al. | — | 2011 | → |
| Modeling tumor invasion and metastasis in Drosophila. | Miles WO et al. | — | 2011 | → |
| Small-molecule ligands of methyl-lysine binding proteins. | Herold JM et al. | — | 2011 | → |
| [Myelodysplastic syndromes]. | Solary E et al. | — | 2010 | → |